These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antigen specificity of immune suppression by myeloid-derived suppressor cells. Solito S; Bronte V; Mandruzzato S J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906 [TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Tadmor T; Attias D; Polliack A Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210 [TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cell role in tumor-related inflammation. Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992 [TBL] [Abstract][Full Text] [Related]
10. Amino acid metabolism related to immune tolerance by MDSCs. Yang B; Wang X; Ren X Int Rev Immunol; 2012 Jun; 31(3):177-83. PubMed ID: 22587019 [TBL] [Abstract][Full Text] [Related]
11. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4. Zhang B; Jia H; Liu J; Yang Z; Jiang T; Tang K; Li D; Huang C; Ma J; Shen GX; Ye D; Huang B J Immunol; 2010 Dec; 185(12):7199-206. PubMed ID: 21068404 [TBL] [Abstract][Full Text] [Related]
12. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice. Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890 [TBL] [Abstract][Full Text] [Related]
13. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167 [TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine. Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833 [TBL] [Abstract][Full Text] [Related]
15. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314 [TBL] [Abstract][Full Text] [Related]
17. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs. Kim YS; Kim YJ; Lee JM; Kim EK; Park YJ; Choe SK; Ko HJ; Kang CY J Immunol; 2012 May; 188(9):4226-34. PubMed ID: 22474024 [TBL] [Abstract][Full Text] [Related]
18. Myeloid-derived suppressor cell heterogeneity in human cancers. Solito S; Marigo I; Pinton L; Damuzzo V; Mandruzzato S; Bronte V Ann N Y Acad Sci; 2014 Jun; 1319():47-65. PubMed ID: 24965257 [TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in human cancer. Nagaraj S; Gabrilovich DI Cancer J; 2010; 16(4):348-53. PubMed ID: 20693846 [TBL] [Abstract][Full Text] [Related]
20. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells. Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]